Aspirin use in adults : cancer, all-cause mortality, and harms : a systematic evidence review for the U.S. Preventive Services Task Force /
BACKGROUND: Cancer is the second leading cause of death in United States. The net benefit for aspirin (ASA) in cardiovascular disease (CVD) primary prevention is controversial due to increased risks from bleeding alongside relatively modest cardiovascular benefits. Consideration of additional cancer...
Saved in:
Main Authors: | Whitlock, Evelyn P. (Author), Williams, Selvi (Author), Burda, Brittany U. (Author), Feightner, Alisha (Author), Beil, Tracy (Author) |
---|---|
Corporate Author: | Oregon Evidence-based Practice Center (Center for Health Research (Kaiser-Permanente Medical Care Program. Northwest Region)) |
Format: | Electronic eBook |
Language: | English |
Published: |
Rockville, MD :
Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services,
[2015]
|
Series: | Evidence syntheses ;
no. 132. AHRQ publication ; no. 13-05193-EF-1. |
Subjects: | |
Online Access: | http://www.ncbi.nlm.nih.gov/books/NBK321643/ |
Similar Items
-
Acetylsalicylic acid
by: Schrör, Karsten
Published: (2009) -
Low-dose aspirin for the prevention of morbidity and mortality from preeclampsia : a systematic evidence review for the U.S. Preventive Services Task Force
by: Henderson, Jillian T.
Published: (2014) -
Aspirin use for the prevention of colorectal cancer : an updated systematic evidence review for the U.S. Preventive Services Task Force
by: Chubak, Jessica, et al.
Published: (2015) -
Aspirin for the primary prevention of cardiovascular events : a systematic evidence review for the U.S. Preventive Services Task Force
by: Guirguis-Blake, Janelle
Published: (2015) -
Acetylsalicylic acid for venous thromboembolism prophylaxis in total hip or knee replacement : a review of clinical effectiveness and guidelines
by: Tran, Khai, active 2010, et al.
Published: (2020)